Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm provides MPS Clinical Program update

Aug 8, 2022 at 3:24 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment